| Identification of genetically intact HIV-1 proviruses in specific CD4+ T cells from effectively treated participants B Hiener, BA Horsburgh, JS Eden, K Barton, TE Schlub, E Lee, ... Cell reports 21 (3), 813-822, 2017 | 365 | 2017 |
| Longitudinal genetic characterization reveals that cell proliferation maintains a persistent HIV type 1 DNA pool during effective HIV therapy S Von Stockenstrom, L Odevall, E Lee, E Sinclair, P Bacchetti, M Killian, ... The Journal of infectious diseases 212 (4), 596-607, 2015 | 184 | 2015 |
| HIV rebound is predominantly fueled by genetically identical viral expansions from diverse reservoirs MA De Scheerder, B Vrancken, S Dellicour, T Schlub, E Lee, W Shao, ... Cell host & microbe 26 (3), 347-358. e7, 2019 | 145 | 2019 |
| Identification of SARS-CoV-2 nucleocapsid and spike T-cell epitopes for assessing T-cell immunity E Lee, K Sandgren, G Duette, VV Stylianou, R Khanna, JS Eden, E Blyth, ... Journal of Virology 95 (6), 10.1128/jvi. 02002-20, 2021 | 62 | 2021 |
| The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells G Duette, B Hiener, H Morgan, FG Mazur, V Mathivanan, BA Horsburgh, ... The Journal of clinical investigation 132 (7), 2022 | 54 | 2022 |
| Memory CD4+ T-cells expressing HLA-DR contribute to HIV persistence during prolonged antiretroviral therapy E Lee, P Bacchetti, J Milush, W Shao, E Boritz, D Douek, R Fromentin, ... Frontiers in microbiology 10, 2214, 2019 | 49 | 2019 |
| Identification of genetically intact HIV-1 proviruses in specific CD4 (+) T cells from effectively treated participants. Cell Rep 21: 813–822 B Hiener, BA Horsburgh, JS Eden, K Barton, TE Schlub, E Lee, ... | 38 | 2017 |
| High levels of genetically intact HIV in HLA-DR+ memory T cells indicates their value for reservoir studies BA Horsburgh, E Lee, B Hiener, JS Eden, TE Schlub, S von Stockenstrom, ... Aids 34 (5), 659-668, 2020 | 35 | 2020 |
| Impact of antiretroviral therapy duration on HIV-1 infection of T cells within anatomic sites E Lee, S von Stockenstrom, V Morcilla, L Odevall, B Hiener, W Shao, ... Journal of virology 94 (3), 10.1128/jvi. 01270-19, 2020 | 23 | 2020 |
| Plasma-derived HIV-1 virions contain considerable levels of defective genomes K Fisher, XQ Wang, A Lee, V Morcilla, A de Vries, E Lee, JS Eden, ... Journal of Virology 96 (6), e02011-21, 2022 | 19 | 2022 |
| Plasmacytoid dendritic cells have divergent effects on HIV infection of initial target cells and induce a pro-retention phenotype O Tong, G Duette, TR O’Neil, CM Royle, H Rana, B Johnson, N Popovic, ... PLoS pathogens 17 (4), e1009522, 2021 | 11 | 2021 |
| Cellular activation, differentiation, and proliferation influence the dynamics of genetically intact proviruses over time BA Horsburgh, B Hiener, K Fisher, E Lee, H Morgan, JS Eden, ... The Journal of infectious diseases 225 (7), 1168-1178, 2022 | 10 | 2022 |
| Distinct HIV genetic populations in effector memory T-cells after prolonged therapy E Lee, B Hiener, P Bacchetti, W Shao, E Boritz, D Douek, M Somsouk, ... 2015 Towards an HIV Cure Symposium, 2015 | 3 | 2015 |
| Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity G Duette, E Lee, G Martins Costa Gomes, K Tungatt, C Doyle, ... ImmunoHorizons 7 (6), 508-527, 2023 | 1 | 2023 |
| Intact proviruses from naive and effector memory T-cells match persistent viremia K Fisher, B Hiener, TE Schlub, E Lee, JM Milush, R Hoh, R Fromentin, ... | 1 | 2019 |
| The impact of treatment duration on defective and expanded identical HIV genomes in T-cell subsets from peripheral blood and tissues E Lee, S von Stockenstrom, V Morcilla, L Odevall, B Hiener, W Show, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 20, 2-3, 2017 | 1 | 2017 |
| Memory CD4+ T cells expressing HLA-DR contribute to HIV persistence during prolonged art E Lee, B Hiener, P Bacchetti, W Shao, E Boritz, D Douek, R Fromentin, ... the 21st international AIDS conference, Durban, South Africa, 2016 | 1 | 2016 |
| PP 1.13–00078 CTL epitopes from structurally important hiv proteins are identified in rebound HIV E Lee, G Duette, K Fisher, S Deeks, A Kelleher, S Palmer | | 2022 |
| DEFINING IMMUNOGENIC PEPTIDES TARGETING SARS-CoV-2 VARIANTS of CONCERN E Lee, G Duette, GM Costa Gomes, K Tungatt, C Doyle, A Lee, ... Topics in Antiviral Medicine, 121-121, 2022 | | 2022 |
| Defining CTL immunotherapy candidates against replication-competent and defective HIV. E Lee, B Horsburgh, T Schlub, J Milush, R Hoh, S Deeks, S Palmer Journal of the International AIDS Society 24 (S4), 6-8, 2021 | | 2021 |
